These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 17595258

  • 21. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
    Attie KM, Julius JR, Stoppani C, Rundle AC.
    J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
    [Abstract] [Full Text] [Related]

  • 22. Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables.
    Ranke MB, Lindberg A, KIGS International Board.
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1229-37. PubMed ID: 20097713
    [Abstract] [Full Text] [Related]

  • 23. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
    Baş F, Darendeliler F, Aycan Z, Çetinkaya E, Berberoğlu M, Sıklar Z, Öcal G, Timirci Ö, Çetinkaya S, Darcan Ş, Gökşen Şimşek D, Bideci A, Cinaz P, Böber E, Demir K, Bereket A, Turan S, Atabek ME, Tütüncüler F, Isbir T, Bozkurt N, Kabataş Eryılmaz S, Uzunhan O, Küçükemre Aydın B, Bundak R.
    Horm Res Paediatr; 2012 Mar; 77(2):85-93. PubMed ID: 22456308
    [Abstract] [Full Text] [Related]

  • 24. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R, Mugnier E, Limoni C, Crosnier H, Czernichow P, Leger J, Limal JM, Rochiccioli P, Soskin S.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
    [Abstract] [Full Text] [Related]

  • 25. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome.
    Rosenfield RL, Devine N, Hunold JJ, Mauras N, Moshang T, Root AW.
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6424-30. PubMed ID: 16189255
    [Abstract] [Full Text] [Related]

  • 26. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E, Diene G, Oliver I, Gennero I, Salles JP, Arnaud C, Tauber M.
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [Abstract] [Full Text] [Related]

  • 27. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
    Bouhours-Nouet N, Gatelais F, Boux de Casson F, Rouleau S, Coutant R.
    J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
    [Abstract] [Full Text] [Related]

  • 28. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 29. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
    Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotterill AM, Hall K, Chatelain PG, Preece MA, Rosenfeld RG.
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
    [Abstract] [Full Text] [Related]

  • 30. Growth and Adult Height in Girls With Turner Syndrome Following IGF-1 Titrated Growth Hormone Treatment.
    Cleemann Wang A, Hagen CP, Nedaeifard L, Juul A, Jensen RB.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):. PubMed ID: 32421787
    [Abstract] [Full Text] [Related]

  • 31. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
    Romano AA, Dana K, Bakker B, Davis DA, Hunold JJ, Jacobs J, Lippe B.
    J Clin Endocrinol Metab; 2009 Jul 01; 94(7):2338-44. PubMed ID: 19401366
    [Abstract] [Full Text] [Related]

  • 32. The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.
    Menke LA, Sas TC, van Koningsbrugge SH, de Ridder MA, Zandwijken GR, Boersma B, Dejonckere PH, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM.
    J Voice; 2011 Sep 01; 25(5):602-10. PubMed ID: 20971614
    [Abstract] [Full Text] [Related]

  • 33. Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial.
    Stephure DK, Canadian Growth Hormone Advisory Committee.
    J Clin Endocrinol Metab; 2005 Jun 01; 90(6):3360-6. PubMed ID: 15784709
    [Abstract] [Full Text] [Related]

  • 34. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A, Bozzola M, Cesarone A, Steenbergh PH, Holthuizen PE, Severi F, Giordano G, Minuto F.
    J Clin Endocrinol Metab; 1998 Oct 01; 83(10):3534-41. PubMed ID: 9768660
    [Abstract] [Full Text] [Related]

  • 35. Safety of growth hormone treatment in pediatric patients with idiopathic short stature.
    Quigley CA, Gill AM, Crowe BJ, Robling K, Chipman JJ, Rose SR, Ross JL, Cassorla FG, Wolka AM, Wit JM, Rekers-Mombarg LT, Cutler GB.
    J Clin Endocrinol Metab; 2005 Sep 01; 90(9):5188-96. PubMed ID: 15899952
    [Abstract] [Full Text] [Related]

  • 36. Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome.
    Davenport ML, Roush J, Liu C, Zagar AJ, Eugster E, Travers S, Fechner PY, Quigley CA.
    Horm Res Paediatr; 2010 Sep 01; 74(1):23-32. PubMed ID: 20424424
    [Abstract] [Full Text] [Related]

  • 37. High-dose growth hormone treatment of short children born small for gestational age.
    de Zegher F, Maes M, Gargosky SE, Heinrichs C, Du Caju MV, Thiry G, De Schepper J, Craen M, Breysem L, Löfström A, Jönsson P, Bourguignon JP, Malvaux P, Rosenfeld RG.
    J Clin Endocrinol Metab; 1996 May 01; 81(5):1887-92. PubMed ID: 8626853
    [Abstract] [Full Text] [Related]

  • 38. Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion.
    Živičnjak M, Schnabel D, Staude H, Even G, Marx M, Beetz R, Holder M, Billing H, Fischer DC, Rabl W, Schumacher M, Hiort O, Haffner D, Hypophosphatemic Rickets Study Group of the Arbeitsgemeinschaft für Pädiatrische Endokrinologie and Gesellschaft für Pädiatrische Nephrologie.
    J Clin Endocrinol Metab; 2011 Dec 01; 96(12):E2097-105. PubMed ID: 21994957
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF, Siemensma EP, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Bocca G, Houdijk EC, Hoorweg-Nijman JJ, Vreuls RC, Jira PE, van Trotsenburg AS, Bakker B, Schroor EJ, Pilon JW, Wit JM, Drop SL, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2009 Nov 01; 94(11):4205-15. PubMed ID: 19837938
    [Abstract] [Full Text] [Related]

  • 40. Growth hormone treatment of girls with Turner syndrome: the National Cooperative Growth Study experience.
    Plotnick L, Attie KM, Blethen SL, Sy JP.
    Pediatrics; 1998 Aug 01; 102(2 Pt 3):479-81. PubMed ID: 9685447
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.